Ilana Stancovski

Technion – Israel Institute of Technology — Israel

Medicine · Health Sciences

14h-index2.0kcitations14works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(7), HER2/EGFR in Cancer Research(6), Ubiquitin and proteasome pathways(5), Glycosylation and Glycoproteins Research(4), Cancer-related Molecular Pathways(2)

Publications14 total

NF-κB Activation: The IκB Kinase Revealed?
Cell·1997· 493 cited
Ubiquitin-dependent Degradation of Certain Protein Substrates in Vitro Requires the Molecular Chaperone Hsc70
Journal of Biological Chemistry·1997· 293 citedOpen Access
Isolation, Characterization, and Partial Purification of a Novel Ubiquitin-Protein Ligase, E3
Journal of Biological Chemistry·1996· 38 citedOpen Access
Degradation of the Proto-Oncogene Product c-Fos by the Ubiquitin Proteolytic System In Vivo and In Vitro: Identification and Characterization of the Conjugating Enzymes
Molecular and Cellular Biology·1995· 167 citedOpen Access
Ubiquitin-mediated Processing of NF-κB Transcriptional Activator Precursor p105
Journal of Biological Chemistry·1995· 149 citedOpen Access
Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake.
Proceedings of the National Academy of Sciences·1995· 147 citedOpen Access
The Ubiquitin-mediated Proteolytic System: Involvement of Molecular Chaperones, Degradation of Oncoproteins, and Activation of Transcriptional Regulators
Cold Spring Harbor Symposia on Quantitative Biology·1995· 30 cited
Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase
Cancer treatment and research·1994· 28 cited
Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.
The Journal of Immunology·1993· 211 citedOpen Access
Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
PubMed·1993· 106 cited
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
The Journal of Steroid Biochemistry and Molecular Biology·1992· 24 cited
Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
PubMed·1992· 103 cited
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth.
Proceedings of the National Academy of Sciences·1991· 206 cited
A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma
Bioconjugate Chemistry·1990· 17 cited

Frequent Co-authors

Michael Sela(6), Aaron Ciechanover(5), Esther Hurwitz(5), Alan L. Schwartz(4), Yosef Yarden(4), Beatrice Bercovich(3), Amir Orian(3), Andrei Laszlo(2), Hedva Gonen(2), S S Bacus(2), D Chin(2), Elior Peles(2), Y Yarden(2), D Baltimore(1), Arie Mayer(1), Nava Blumenfeld(1), Daniel Schindler(1), Tova Waks(1), Zelig Eshhar(1), O. Leitner(1)